Nature Immunology, Published online: 27 May 2024; doi:10.1038/s41590-024-01851-8CAR T cell technology is being extended beyond the treatment of cancer. New data show that it might also treat allergic asthma, with a single infusion sufficient to prevent pathology for over a year in mice.

Nature Immunology, Published online: 27 May 2024; doi:10.1038/s41590-024-01834-9CAR T cells have shown great promise in treating some cancers and are now being applied to other diseases. Here the authors engineer mouse and human T cells and show that a single infusion can result in lasting remission from asthma in mice.

Nature Immunology, Published online: 27 May 2024; doi:10.1038/s41590-024-01855-4Here the authors identify and characterize the development and function of an IFN-γ-producing CD8αβ+ subset of γδ T cells that contributes to malignancy.

Nature Immunology, Published online: 23 May 2024; doi:10.1038/s41590-024-01863-4Author Correction: c-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes host–microbiota homeostasis

Nature Immunology, Published online: 16 May 2024; doi:10.1038/s41590-024-01864-3Publisher Correction: PU.1 and BCL11B sequentially cooperate with RUNX1 to anchor mSWI/SNF to poise the T cell effector landscape

Nature Immunology, Published online: 15 May 2024; doi:10.1038/s41590-024-01842-9The National Institute of Allergy and Infectious Diseases (NIAID) hosted a two-day virtual workshop on leveraging microbial exposure to improve mouse models of human immune status and disease. The workshop’s objective was to evaluate the current state of knowledge in the...